GlassScriptPhysician profile
Sean B Bohannon
NPI 1881851491
$5,933.99
in general payments reported to CMS, 2019-2025
33 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $1,284 · 2021: $1,218 · 2022: $641 · 2023: $646 · 2024: $461 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.45 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,554.00 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $741.57 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $491.24 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $471.89 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $274.80 | 2019-2022 | |
| Grifols USA, LLC | $242.22 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $237.45 | 2019-2020 | |
| Glaxosmithkline, LLC. | $215.07 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $167.89 | 2021-2025 | |
| Mylan Specialty L.P. | $162.15 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.38 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $143.12 | 2019-2022 | |
| Abbott Laboratories | $132.13 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $127.23 | 2023 | Veozah, Myrbetriq |
| Ironwood Pharmaceuticals, INC | $94.12 | 2021-2024 | Linzess |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $78.32 | 2019-2021 | |
| Global Blood Therapeutics, INC. | $71.72 | 2021-2022 | |
| Dexcom, INC. | $67.89 | 2021-2023 | Dexcom G6 Transmitter |
| Amgen INC. | $59.43 | 2019 | |
| Boston Scientific Corporation | $57.20 | 2020 | |
| Pfizer INC. | $55.19 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.23 | 2024 | |
| Sumitomo Pharma America, INC. | $43.66 | 2023 | Gemtesa |
| Allergan, INC. | $40.77 | 2020 | |
| Radiometer America, INC | $40.35 | 2025 | |
| Exact Sciences Corporation | $29.87 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $24.34 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.38 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $20.43 | 2025 | Rexulti |
| Avion Pharmaceuticals | $18.26 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $17.06 | 2019 | |
| Strongbridge US INC. | $15.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Bohannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.